Carmelo Gurnari, Hematologist/Oncologist and Researcher at Cleveland Clinic, shared an article on X:
“What an honor to present the updated recommendations for allo-HCT in MDS in our genomic era on behalf of an international panel and the EBMT.
Thanks everybody for such a prototypic example of collaboration and team work!
Highlights here.”
Clinical-genomic profiling of MDS to inform allo-HSCT: Recommendations from an international panel on behalf of the EBMT.
Authors: Carmelo Gurnari, et al.
